Substance with immunomodulator mechanism of action (substance)
| Code | 372558009 |
|---|---|
| Semantic tag | substance |
| Module | international |
| Definition | defined |
| Effective time | 20180131 |
766739005Substance categorized by disposition
substance
91309004Acute phase reactant
substance
372669002Alkylating agent
substance
372612001Antifolate
substance
372785000Antimetabolite
substance
1367858003Bacterial lysate
substance
449043000Belimumab
substance
116571008Betamethasone
substance
331794004Betamethasone ester
substance
116573006Betamethasone sodium phosphate
substance
409400001Cetuximab
substance
8491006Complement inhibitor
substance
106192008Complement related substance
substance
45874411000001107Deuruxolitinib
substance
45874511000001106Deuruxolitinib phosphate
substance
724035008Dimethyl fumarate
substance
1363209009Epcoritamab
substance
116588001Flunisolide
substance
420884001Human mesenchymal stem cell
substance
386941002Imiquimod
substance
870400009Immune checkpoint inhibitor
substance
372861001Immune enhancement agent
substance
372823004Immunosuppressant
substance
395749001Inosine acedoben dimepranol
substance
43801311000001102Lecanemab
substance
386981009Leflunomide
substance
421471009Lenalidomide
substance
487861000202101Lenalidomide ammonium chloride
substance
736951007Lymphocyte function-associated antigen 1 antagonist
substance
767722000Mediator of immune response and inflammation
substance
710284002Mifamurtide
substance
372542006Mitotic inhibitor
substance
733464008Ocrelizumab
substance
703789000Pomalidomide
substance
409218001Proteasome inhibitor
substance
786995002Sphingosine 1-phosphate receptor agonist
substance
1359773000Sphingosine 1-phosphate receptor antagonist
substance
716044007Substance with interleukin receptor antagonist mechanism of action
substance
420693002Substance with tumor necrosis factor alpha inhibitor mechanism of action
substance
276261000087109Teplizumab
substance
703785006Teriflunomide
substance
422261006Thymalfasin
substance
395912000Treosulfan
substance